• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Tartu University Hospital expands Clinerion’s PRS network of hospitals into Estonia.

Tartu University Hospital expands Clinerion’s PRS network of hospitals into Estonia.

November 27, 2017
CenterWatch Staff

Tartu University Hospital, the only university hospital in Estonia and an eHealth pioneer, has joined the network of hospitals on Clinerion’s PRS platform.

Tartu University Hospital was established in 1804 and is the only university hospital in Estonia. It covers all medical fields from nursing care to oncology and organ transplantation. The hospital has a catchment area which covers ~50% of the Estonian population. It performs 40,000 inpatient treatments and receives 400,000 outpatient visits annually.

Tartu University Hospital is the pioneer of eHealth in Estonia. 80% of its medical data communication is digital.

Tartu University Hospital currently runs 30-40 clinical trials per year, with capacity to do many more, and the expertise to back it up. By joining, the PRS platform, the university hospital’s clinical trials facilities will be exposed to a wide range of global clinical trials run by Clinerion’s clients, international pharmaceutical companies and contract research organizations.

“Cooperation with Clinerion will make our immense trial capabilities and expertise more visible and accessible internationally. It will certainly bring Tartu more trials at the cutting edge of medical innovation. With our partnership, we also hope to improve our data quality and harmonize our coding practices to international standards,” said Margus Ulst, Chief Medical Officer of Tartu University Hospital.

“Clinerion’s coverage is on a steep expansion curve. We are thrilled to expand our footprint to Estonia,” said Ulf Claesson, CEO of Clinerion. “Tartu University Hospital is a particularly welcome partner for our platform due to its great clinical facilities and high digitization level.”

Clinerion’s network now covers Europe, Asia, South America and North America, with around 150 M patients searchable for trials. The PRS solution queries electronic patient health records to offer patient search and identification for clinical trials, as well as report generation for real-world evidence and market access exercises. PRS utilizes Clinerion’s proprietary “Anonymized Identification” technology, which ensures patient privacy by performing patient search and identification from fully anonymized records.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing